Essential thrombocythemia: a rare disease in childhood
Autor(a) principal: | |
---|---|
Data de Publicação: | 2013 |
Outros Autores: | |
Tipo de documento: | Relatório |
Idioma: | eng |
Título da fonte: | Revista brasileira de hematologia e hemoterapia (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842013000400287 |
Resumo: | Essential thrombocythemia is an acquired myeloproliferative disorder characterized by the proliferation of megakaryocytes in bone marrow, leading to a persistent increase in the number of circulating platelets and thus increasing the risk for thrombotic and hemorrhagic events. The disease features leukocytosis, splenomegaly, vascular occlusive events, hemorrhages and vasomotor disorders. The intricate mechanisms underlying the molecular pathogenesis of this disorder are not completely understood and are still a matter of discussion. Essential thrombocythemia is an extremely rare disorder during childhood. We report on a case of essential thrombocythemia in a child and discuss the diagnostic approach and treatment strategy. |
id |
ABHHTC-1_21aee0844156aa40d14df9c1a0d1304d |
---|---|
oai_identifier_str |
oai:scielo:S1516-84842013000400287 |
network_acronym_str |
ABHHTC-1 |
network_name_str |
Revista brasileira de hematologia e hemoterapia (Online) |
repository_id_str |
|
spelling |
Essential thrombocythemia: a rare disease in childhoodThrombocythemia, essential/drug therapyThrombocytosisThrombosisMyelodysplastic-myeloproliferative diseasesPlatelet aggregation inhibitors/therapeutic useHydroxyurea/therapeutic useHumansCase reportsFemaleChildEssential thrombocythemia is an acquired myeloproliferative disorder characterized by the proliferation of megakaryocytes in bone marrow, leading to a persistent increase in the number of circulating platelets and thus increasing the risk for thrombotic and hemorrhagic events. The disease features leukocytosis, splenomegaly, vascular occlusive events, hemorrhages and vasomotor disorders. The intricate mechanisms underlying the molecular pathogenesis of this disorder are not completely understood and are still a matter of discussion. Essential thrombocythemia is an extremely rare disorder during childhood. We report on a case of essential thrombocythemia in a child and discuss the diagnostic approach and treatment strategy.Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular2013-01-01info:eu-repo/semantics/reportinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842013000400287Revista Brasileira de Hematologia e Hemoterapia v.35 n.4 2013reponame:Revista brasileira de hematologia e hemoterapia (Online)instname:Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)instacron:ABHHTC10.5581/1516-8484.20130059info:eu-repo/semantics/openAccessBeatrice,Julia MaimoneGaranito,Marlene Pereiraeng2013-10-10T00:00:00Zoai:scielo:S1516-84842013000400287Revistahttp://www.rbhh.org/pt/archivo/https://old.scielo.br/oai/scielo-oai.phpsbhh@terra.com.br||secretaria@rbhh.org1806-08701516-8484opendoar:2013-10-10T00:00Revista brasileira de hematologia e hemoterapia (Online) - Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)false |
dc.title.none.fl_str_mv |
Essential thrombocythemia: a rare disease in childhood |
title |
Essential thrombocythemia: a rare disease in childhood |
spellingShingle |
Essential thrombocythemia: a rare disease in childhood Beatrice,Julia Maimone Thrombocythemia, essential/drug therapy Thrombocytosis Thrombosis Myelodysplastic-myeloproliferative diseases Platelet aggregation inhibitors/therapeutic use Hydroxyurea/therapeutic use Humans Case reports Female Child |
title_short |
Essential thrombocythemia: a rare disease in childhood |
title_full |
Essential thrombocythemia: a rare disease in childhood |
title_fullStr |
Essential thrombocythemia: a rare disease in childhood |
title_full_unstemmed |
Essential thrombocythemia: a rare disease in childhood |
title_sort |
Essential thrombocythemia: a rare disease in childhood |
author |
Beatrice,Julia Maimone |
author_facet |
Beatrice,Julia Maimone Garanito,Marlene Pereira |
author_role |
author |
author2 |
Garanito,Marlene Pereira |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Beatrice,Julia Maimone Garanito,Marlene Pereira |
dc.subject.por.fl_str_mv |
Thrombocythemia, essential/drug therapy Thrombocytosis Thrombosis Myelodysplastic-myeloproliferative diseases Platelet aggregation inhibitors/therapeutic use Hydroxyurea/therapeutic use Humans Case reports Female Child |
topic |
Thrombocythemia, essential/drug therapy Thrombocytosis Thrombosis Myelodysplastic-myeloproliferative diseases Platelet aggregation inhibitors/therapeutic use Hydroxyurea/therapeutic use Humans Case reports Female Child |
description |
Essential thrombocythemia is an acquired myeloproliferative disorder characterized by the proliferation of megakaryocytes in bone marrow, leading to a persistent increase in the number of circulating platelets and thus increasing the risk for thrombotic and hemorrhagic events. The disease features leukocytosis, splenomegaly, vascular occlusive events, hemorrhages and vasomotor disorders. The intricate mechanisms underlying the molecular pathogenesis of this disorder are not completely understood and are still a matter of discussion. Essential thrombocythemia is an extremely rare disorder during childhood. We report on a case of essential thrombocythemia in a child and discuss the diagnostic approach and treatment strategy. |
publishDate |
2013 |
dc.date.none.fl_str_mv |
2013-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/report |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
report |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842013000400287 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842013000400287 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.5581/1516-8484.20130059 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular |
publisher.none.fl_str_mv |
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular |
dc.source.none.fl_str_mv |
Revista Brasileira de Hematologia e Hemoterapia v.35 n.4 2013 reponame:Revista brasileira de hematologia e hemoterapia (Online) instname:Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC) instacron:ABHHTC |
instname_str |
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC) |
instacron_str |
ABHHTC |
institution |
ABHHTC |
reponame_str |
Revista brasileira de hematologia e hemoterapia (Online) |
collection |
Revista brasileira de hematologia e hemoterapia (Online) |
repository.name.fl_str_mv |
Revista brasileira de hematologia e hemoterapia (Online) - Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC) |
repository.mail.fl_str_mv |
sbhh@terra.com.br||secretaria@rbhh.org |
_version_ |
1754213111991107584 |